Eupraxia Pharmaceuticals (EPRX) Other Non-Current Assets (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Other Non-Current Assets of $53,702 in the quarter ended Jun 30, 2026, down 31.0% from $77,842 a year earlier and down 13.0% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Other Non-Current Assets (2022 - 2026) Analysis & Trends
As of Dec 31, 2025, Eupraxia Pharmaceuticals reported Other Non-Current Assets of $64,332, down 20.3% from the prior year.
- Annual Other Non-Current Assets has a three-year compound annual growth rate of 195.5% (years ended Dec 2022 to Dec 2025).
- Across earlier years, Other Non-Current Assets came in at $80,761 in the year ended Dec 31, 2024, $6,904 in the year ended Dec 31, 2023 (+177.0%) and $2,492 in the year ended Dec 31, 2022.
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Other Non-Current Assets since the quarter ended Mar 31, 2024.
- On a year-over-year basis, Other Non-Current Assets has declined for five consecutive quarters, with an average decline of 51.7% over the last five quarters.
- Per Business Quant, the preceding three quarters came in at $61,754 (quarter ended Mar 31, 2026), $64,332 (quarter ended Dec 31, 2025) and $97,597 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Eupraxia Pharmaceuticals | 363.60 Mn | 362.00 Mn | - | 53,702.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53,702.00 |
| Mar 31, 2026 | 61,754.00 |
| Dec 31, 2025 | 64,332.00 |
| Sep 30, 2025 | 97,597.00 |
| Jun 30, 2025 | 77,842.00 |
| Mar 31, 2025 | 80,230.00 |
| Dec 31, 2024 | 80,761.00 |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 5,571.00 |
| Dec 31, 2023 | 6,904.00 |
| Dec 31, 2022 | 2,492.00 |
API Access
Eupraxia Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();